Showing 1 - 20 results of 28 for search '"hematopoietic stem cell"', query time: 0.09s Refine Results
  1. 1

    Risk factors associated with hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation by Biao Shen, Yueshen Ma, Haixiao Zhang, Mingyang Wang, Jia Liu, Jiaxin Cao, Wenwen Guo, Dan Feng, Donglin Yang, Rongli Zhang, Xin Chen, Qiaoling Ma, Weihua Zhai, Sizhou Feng, Mingzhe Han, Aiming Pang, Erlie Jiang

    Published 2022-04-01
    “…Hemorrhagic cystitis (HC) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT). The incidence is about 7% to 68%, and some patients have to suffer a long period of frequent, urgent, and painful urination, which brings great pain. …”
    Get full text
    Article
  2. 2
  3. 3
  4. 4

    Hematopoietic stem cell transplantation from an infected SARS-CoV2 haploidentical donor: A case report by Xin Chen, Qiaoling Ma, Aiming Pang, Donglin Yang, Chen Liang, Qingzhen Liu, Xin Liu, Xiaohui Zheng, Erlie Jiang, Mingzhe Han, Sizhou Feng

    Published 2023-01-01
    “…Introduction: We report a case of an adult hematopoietic stem cell donor who developed active severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the donation of stem cells, the final transplantation was successfully completed without SARS-CoV-2 transmission. …”
    Get full text
    Article
  5. 5
  6. 6
  7. 7

    Comparison of hematopoietic stem cell transplantation and immunosuppressive therapy as the first-line treatment option for patients with severe hepatitis−associated aplastic anemia by Xiaoyu Zhang, Xiaoyu Zhang, Wenrui Yang, Wenrui Yang, Donglin Yang, Donglin Yang, Jialin Wei, Jialin Wei, Ping Zhang, Sizhou Feng, Sizhou Feng, Erlie Jiang, Erlie Jiang, Li Zhang, Li Zhang, Yi He, Yi He, Fengkui Zhang, Fengkui Zhang, Mingzhe Han, Mingzhe Han

    Published 2023-03-01
    “…We retrospectively analyzed the outcomes of consecutive severe HAAA patients who received immunosuppressive therapy (IST, n = 70), matched-sibling donor hematopoietic stem cell transplantation (MSD-HSCT, n = 26) or haploidentical-donor (HID) HSCT (n = 11) as the first-line treatment. …”
    Get full text
    Article
  8. 8
  9. 9

    Outcomes of acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: validation, comparison and improvement of 2022 ELN genetic risk system by Haixiao Zhang, Xinhui Zheng, Wenwen Guo, Yonghui Xia, Rongli Zhang, Weihua Zhai, Xin Chen, Qiaoling Ma, Donglin Yang, Jialin Wei, Aiming Pang, Yi He, Sizhou Feng, Jianxiang Wang, Mingzhe Han, Erlie Jiang

    Published 2024-02-01
    “…Abstract The 2022 European LeukemiaNet (ELN) updated the previous risk classification published in 2017 but the prognostic significance for allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains unclear. …”
    Get full text
    Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20